Market research
WBA Walgreens Boots Alliance Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 10B
- P/E ratio
- Not available
- Analyst target
- 12.1143
- Dividend yield
- 4.2%
- Beta
- 0.77
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- ISIN
- US9314271084
- Market cap
- 10B
- P/E ratio
- Not available
- Analyst target
- 12.1143
- Dividend yield
- 4.2%
- Beta
- 0.77
About
About Walgreens Boots Alliance Inc
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the WBA discussion.
5 years, 4 months ago
Walgreens Boots Alliance, Inc is currently in a long term downtrend where the price is trading 0.9% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.
Walgreens Boots Alliance, Inc's total revenue sank by 8.5% to $33B since the same quarter in the previous year.
Its net income has increased by 8.5% to $1B since the same quarter in the previous year.
Finally, its free cash flow grew by 68.7% to $2B since the same quarter in the previous year.
Based on the above factors, Walgreens Boots Alliance, Inc gets an overall score of 3/5.